Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 432

1.

Griffiths et al.'s comments on the international consensus statement of internet gaming disorder: furthering consensus or hindering progress?

Petry NM, Rehbein F, Gentile DA, Lemmens JS, Rumpf HJ, Mößle T, Bischof G, Tao R, Fung DS, Borges G, Auriacombe M, González-Ibáñez A, Tam P, O'Brien CP.

Addiction. 2016 Jan;111(1):175-8. doi: 10.1111/add.13189. No abstract available.

PMID:
26669531
2.

Bioinformatic Analysis of Antigenic Proteins in Celiac Disease.

O'Brien CP.

Methods Mol Biol. 2015;1326:193-201. doi: 10.1007/978-1-4939-2839-2_16.

PMID:
26498622
3.

Spectators Control Selectivity in Surface Chemistry: Acrolein Partial Hydrogenation Over Pd.

Dostert KH, O'Brien CP, Ivars-Barceló F, Schauermann S, Freund HJ.

J Am Chem Soc. 2015 Oct 28;137(42):13496-502. doi: 10.1021/jacs.5b04363. Epub 2015 Oct 20.

4.

Water Interaction with Iron Oxides.

Dementyev P, Dostert KH, Ivars-Barceló F, O'Brien CP, Mirabella F, Schauermann S, Li X, Paier J, Sauer J, Freund HJ.

Angew Chem Int Ed Engl. 2015 Nov 16;54(47):13942-6. doi: 10.1002/anie.201506439. Epub 2015 Oct 12.

PMID:
26457889
5.

A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence.

Kampman KM, Lynch KG, Pettinati HM, Spratt K, Wierzbicki MR, Dackis C, O'Brien CP.

Drug Alcohol Depend. 2015 Oct 1;155:105-10. doi: 10.1016/j.drugalcdep.2015.08.005. Epub 2015 Aug 14.

PMID:
26320827
6.

Internet Gaming Disorder in the DSM-5.

Petry NM, Rehbein F, Ko CH, O'Brien CP.

Curr Psychiatry Rep. 2015 Sep;17(9):72. doi: 10.1007/s11920-015-0610-0. Review.

PMID:
26216590
7.

Interaction of Isophorone with Pd(111): A Combination of Infrared Reflection-Absorption Spectroscopy, Near-Edge X-ray Absorption Fine Structure, and Density Functional Theory Studies.

Dostert KH, O'Brien CP, Riedel W, Savara A, Liu W, Oehzelt M, Tkatchenko A, Schauermann S.

J Phys Chem C Nanomater Interfaces. 2014 Dec 4;118(48):27833-27842. Epub 2014 Nov 21.

8.

Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence.

Wang AL, Elman I, Lowen SB, Blady SJ, Lynch KG, Hyatt JM, O'Brien CP, Langleben DD.

Transl Psychiatry. 2015 Mar 17;5:e531. doi: 10.1038/tp.2015.20.

9.

Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.

Oslin DW, Leong SH, Lynch KG, Berrettini W, O'Brien CP, Gordon AJ, Rukstalis M.

JAMA Psychiatry. 2015 May;72(5):430-7. doi: 10.1001/jamapsychiatry.2014.3053.

PMID:
25760804
10.

High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.

van den Hurk K, Balint B, Toomey S, O'Leary PC, Unwin L, Sheahan K, McDermott EW, Murphy I, van den Oord JJ, Rafferty M, FitzGerald DM, Moran J, Cummins R, MacEneaney O, Kay EW, O'Brien CP, Finn SP, Heffron CC, Murphy M, Yela R, Power DG, Regan PJ, McDermott CM, O'Keeffe A, Orosz Z, Donnellan PP, Crown JP, Hennessy BT, Gallagher WM.

Melanoma Res. 2015 Jun;25(3):189-99. doi: 10.1097/CMR.0000000000000149.

PMID:
25746038
11.

Limitations of the use of the MP-RAGE to identify neural changes in the brain: recent cigarette smoking alters gray matter indices in the striatum.

Franklin TR, Wetherill RR, Jagannathan K, Hager N, O'Brien CP, Childress AR.

Front Hum Neurosci. 2015 Jan 28;8:1052. doi: 10.3389/fnhum.2014.01052. eCollection 2014. No abstract available.

12.

Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial.

Lee JD, Friedmann PD, Boney TY, Hoskinson RA Jr, McDonald R, Gordon M, Fishman M, Chen DT, Bonnie RJ, Kinlock TW, Nunes EV, Cornish JW, O'Brien CP.

Contemp Clin Trials. 2015 Mar;41:110-7. doi: 10.1016/j.cct.2015.01.005. Epub 2015 Jan 17.

PMID:
25602580
13.

Brief report: "spiders-No, puppies-Go", introducing a novel Go NoGo task tested in inner city adolescents at risk for poor impulse control.

Goldman M, Ehrman RN, Suh JJ, Hurt H, Marquez K, Franklin TR, O'Brien CP, Childress AR.

J Adolesc. 2015 Jan;38:45-8. doi: 10.1016/j.adolescence.2014.10.007. Epub 2014 Nov 24. No abstract available.

14.

Interview with Eddy Award Winner Charles O'Brien, MD, PhD.

O'Brien CP, Denis C.

Drug Alcohol Depend. 2014 Oct 1;143:281-2. No abstract available.

PMID:
25343165
15.

A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence.

Pettinati HM, Kampman KM, Lynch KG, Dundon WD, Mahoney EM, Wierzbicki MR, O'Brien CP.

Am J Addict. 2014 Nov-Dec;23(6):591-7. doi: 10.1111/j.1521-0391.2014.12146.x. Epub 2014 Sep 22.

PMID:
25251201
16.

Moving internet gaming disorder forward: A reply.

Petry NM, Rehbein F, Gentile DA, Lemmens JS, Rumpf HJ, Mößle T, Bischof G, Tao R, Fung DS, Borges G, Auriacombe M, GonzálezIbáñez A, Tam P, O'Brien CP.

Addiction. 2014 Sep;109(9):1412-3. doi: 10.1111/add.12653. No abstract available.

PMID:
25103100
17.

Internet gaming and addiction: a reply to King & Delfabbro.

Petry NM, Rehbein F, Gentile DA, Lemmens JS, Rumpf HJ, Mößle T, Bischof G, Tao R, Fung DS, Borges G, Auriacombe M, GonzálezIbáñez A, Tam P, O'Brien CP.

Addiction. 2014 Sep;109(9):1567-8. doi: 10.1111/add.12549. Epub 2014 Apr 14. No abstract available.

PMID:
24724947
18.

Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues.

Young KA, Franklin TR, Roberts DC, Jagannathan K, Suh JJ, Wetherill RR, Wang Z, Kampman KM, O'Brien CP, Childress AR.

J Neurosci. 2014 Apr 2;34(14):5038-43. doi: 10.1523/JNEUROSCI.4977-13.2014.

19.

Managing patients with a history of substance abuse.

O'Brien CP.

Can Fam Physician. 2014 Mar;60(3):248-50. No abstract available.

20.

Molecular testing in oncology: problems, pitfalls and progress.

O'Brien CP, Taylor SE, O'Leary JJ, Finn SP.

Lung Cancer. 2014 Mar;83(3):309-15. doi: 10.1016/j.lungcan.2013.12.010. Epub 2014 Jan 3. Review.

PMID:
24472389
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk